2-n butyl-3-[(2-cyanobiphenyl-4-yl) methyl]-1,3-diazaspiro [4,4] non-1-en-4-one
Product Description
BDR PHARMACEUTICALS INTERNATIONAL PVT.
-
IN
-
2015On CPHI since
-
1000 - 4999Employees
Company types
Categories
Specifications
BDR PHARMACEUTICALS INTERNATIONAL PVT.
-
IN
-
2015On CPHI since
-
1000 - 4999Employees
Company types
More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)
-
Product [138401-24-8]
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [138401-24-8]. It belongs to irbesartan intermediates products category. Contact us for more information. -
Product 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]. It belongs to ranolazine intermediates products category. Contact us for more information. -
Product 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]. It belongs to ranolazine intermediates products category. Contact us for more information. -
Product 2- thiazine-1,1-dioxide. Cas no : 70417-50-8
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2- thiazine-1,1-dioxide. Cas no : 70417-50-8. It belongs to lornoxicam intermediates products category. Contact us for more information. -
Product 2-(1-adamantyl)-4-bromophenol 2-(1-adamantyl) -4-bromoanisole [104224-63-7]
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-(1-adamantyl)-4-bromophenol 2-(1-adamantyl) -4-bromoanisole [104224-63-7]. It belongs to adapalene intermediates products category. Contact us for more information. -
Product 2-chloro-1, 3-bis (dimethylamino)-trimethinium hexafluorophosphate
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-chloro-1, 3-bis (dimethylamino)-trimethinium hexafluorophosphate. It belongs to etoricoxib intermediates products category. Contact us for more information. -
Product 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-1h-benzimidazole [152628-02-9]. It belongs to telmisartan intermediates products category. Contact us for more information. -
Product 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 2-n-propyl-4-methyl-6(1-methyl benzemidazole-2yl) benzomidazole. It belongs to telmisartan intermediates products category. Contact us for more information. -
Product 4-(3-methylphenyl)amino-3-pyridine sulphonamid
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-(3-methylphenyl)amino-3-pyridine sulphonamid. It belongs to torsemide intermediates products category. Contact us for more information. -
Product 4-(aminomethyl) pyrolidine -3-one-o-methyloxime mesylate
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-(aminomethyl) pyrolidine -3-one-o-methyloxime mesylate. It belongs to gemifloxacin intermediates products category. Contact us for more information. -
Product 4-cyanothiomethylbenzyl-3-(6-methyl)-pyridyl ketone
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-cyanothiomethylbenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information. -
Product 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone
Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 4-methylmercaptobenzyl-3-(6-methyl)-pyridyl ketone. It belongs to etoricoxib intermediates products category. Contact us for more information.
BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)
-
Video BDR Pharmaceuticals INT'L PVT LTD at CPHI Worldwide 2018
Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance